Ventilator Associated Tracheobronchitis: Incidence, Etiology, Predisposing Risk Factors and Drug Resistance

A Study of Incidence and Microbiological Profile of Ventilator Associated Tracheobronchitis (VAT) in a Tertiary Care Hospital

“…But Mayuri et al, in their study reported 18% of patients in the age group of 41-50 years and 13% in the 50 -60 years age group which is similar to our study (Mayuri, 2017).…”

“…78.7% isolates were multi drug resistant in a study by Mayuri (2017). 20.35% of VAT cases were due to pan drug resistant isolates.…”

“…In a study by Mayuri et al, Pseudomonas aeruginosa was the predominant pathogen isolated (29%) followed by Klebsiella pneumoniae (26%), Acinetobacter baumannii (20%), Staphylococcus aureus (12%), Escherichia coli (8%) and Citrobacter freundii (6%) (Mayuri, 2017).…”

“…32.76% had hypertension, 25.86% had diabetes, 17.24% had both diabetes and hypertension and 24.14% had no co morbidities. Mayuri et al, reported 37.2% of patients with diabetes and 30% of patients with hypertension (Mayuri, 2017). Sadek et al, reported 20% of diabetics and 40% of hypertension patients in VAT patients (Sadek et al, 2014).…”